Skip to main content
. Author manuscript; available in PMC: 2009 Nov 21.
Published in final edited form as: J Org Chem. 2008 Oct 22;73(22):8901–8920. doi: 10.1021/jo801312r

Figure 5.

Figure 5

Western blot analyses of Hsp90 client protein degradation assays against MCF-7 breast cancer cells. Concentrations (in μM) of 26g (top), 26j (middle), and 42d (bottom) are indicated above each lane. GDA (geldanamycin, 500 nM) and DMSO were respectively employed as positive and negative controls.